NL181553B - Werkwijze voor de bereiding van een virus-subeenheid-vaccin. - Google Patents
Werkwijze voor de bereiding van een virus-subeenheid-vaccin.Info
- Publication number
- NL181553B NL181553B NLAANVRAGE7413642,A NL7413642A NL181553B NL 181553 B NL181553 B NL 181553B NL 7413642 A NL7413642 A NL 7413642A NL 181553 B NL181553 B NL 181553B
- Authority
- NL
- Netherlands
- Prior art keywords
- preparing
- unit vaccine
- virus sub
- virus
- sub
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16251—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB48685/73A GB1486557A (en) | 1973-10-18 | 1973-10-18 | Process for the preparation of pyrogen-free sub-unit vaccine |
Publications (3)
Publication Number | Publication Date |
---|---|
NL7413642A NL7413642A (nl) | 1975-04-22 |
NL181553B true NL181553B (nl) | 1987-04-16 |
NL181553C NL181553C (nl) | 1987-09-16 |
Family
ID=10449549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NLAANVRAGE7413642,A NL181553C (nl) | 1973-10-18 | 1974-10-17 | Werkwijze voor de bereiding van een virus-subeenheid-vaccin. |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS5082228A (nl) |
AT (1) | AT334524B (nl) |
BE (1) | BE821175A (nl) |
CA (1) | CA1050886A (nl) |
CH (1) | CH611518A5 (nl) |
DE (1) | DE2449530C2 (nl) |
DK (1) | DK138581B (nl) |
FR (1) | FR2248054B1 (nl) |
GB (1) | GB1486557A (nl) |
IE (1) | IE40187B1 (nl) |
IL (1) | IL45870A (nl) |
NL (1) | NL181553C (nl) |
NO (1) | NO142024C (nl) |
SE (1) | SE426439B (nl) |
ZA (1) | ZA746398B (nl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK276380A (da) * | 1979-07-09 | 1981-01-10 | Univ Iowa State Res Found Inc | Fremgangsmaade til fremstilling af en vaccine mod infektioes kvaeg-rhinotracheitis |
FR2470795A1 (fr) * | 1979-12-07 | 1981-06-12 | Pasteur Institut | Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus |
FR2475572A1 (fr) * | 1980-02-11 | 1981-08-14 | Pasteur Institut | Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications |
FR2483779A1 (fr) | 1980-06-05 | 1981-12-11 | Synthelabo | Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins |
DE19938767C2 (de) * | 1999-08-16 | 2002-10-24 | Tad Pharma Gmbh | Spaltimpfstoffe |
BR0114392A (pt) * | 2000-10-02 | 2003-09-02 | Glaxosmithkline Biolog Sa | Formulação de vacina, método para produzir uma formulação de vacina, uso de uma preparação de vacina contra rsv dividido, kit para liberação de uma formulação de vacina intranasal, dispositivo de liberação intranasal, e, método para proteger ou tratar um mamìfero susceptìvel a, ou sofrendo de doença causada por rsv |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3519400A (en) * | 1967-01-25 | 1970-07-07 | Atomic Energy Commission | Method of centrifugal separation and recovery of chemical species utilizing a liquid medium |
-
1973
- 1973-10-18 GB GB48685/73A patent/GB1486557A/en not_active Expired
-
1974
- 1974-10-08 ZA ZA00746398A patent/ZA746398B/xx unknown
- 1974-10-17 NL NLAANVRAGE7413642,A patent/NL181553C/nl not_active IP Right Cessation
- 1974-10-17 IL IL45870A patent/IL45870A/xx unknown
- 1974-10-17 DK DK543974AA patent/DK138581B/da not_active IP Right Cessation
- 1974-10-17 IE IE2141/74A patent/IE40187B1/xx unknown
- 1974-10-17 BE BE149618A patent/BE821175A/xx not_active IP Right Cessation
- 1974-10-17 AT AT835074A patent/AT334524B/de not_active IP Right Cessation
- 1974-10-17 JP JP49119836A patent/JPS5082228A/ja active Pending
- 1974-10-17 DE DE2449530A patent/DE2449530C2/de not_active Expired
- 1974-10-17 SE SE7413113A patent/SE426439B/xx unknown
- 1974-10-17 CH CH1394974A patent/CH611518A5/xx not_active IP Right Cessation
- 1974-10-17 CA CA211,654A patent/CA1050886A/en not_active Expired
- 1974-10-17 NO NO743758A patent/NO142024C/no unknown
- 1974-10-18 FR FR7435179A patent/FR2248054B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DK138581B (da) | 1978-10-02 |
IE40187L (en) | 1975-04-18 |
IL45870A0 (en) | 1974-12-31 |
IL45870A (en) | 1978-03-10 |
NL7413642A (nl) | 1975-04-22 |
CH611518A5 (en) | 1979-06-15 |
FR2248054B1 (nl) | 1978-07-28 |
ZA746398B (en) | 1976-06-30 |
DE2449530C2 (de) | 1985-08-08 |
DK543974A (nl) | 1975-06-16 |
DE2449530A1 (de) | 1975-04-30 |
BE821175A (fr) | 1975-04-17 |
SE426439B (sv) | 1983-01-24 |
JPS5082228A (nl) | 1975-07-03 |
ATA835074A (de) | 1976-05-15 |
DK138581C (nl) | 1979-03-12 |
NO142024C (no) | 1980-06-18 |
NO142024B (no) | 1980-03-10 |
NO743758L (nl) | 1975-05-12 |
AU7444974A (en) | 1976-04-29 |
GB1486557A (en) | 1977-09-21 |
NL181553C (nl) | 1987-09-16 |
FR2248054A1 (nl) | 1975-05-16 |
AT334524B (de) | 1976-01-25 |
SE7413113L (nl) | 1975-04-21 |
IE40187B1 (en) | 1979-03-28 |
CA1050886A (en) | 1979-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL182369C (nl) | Werkwijze voor het bereiden van een oraal geneesmiddelpreparaat met verlengde afgifte. | |
NL7415978A (nl) | Werkwijze voor het bereiden van een kraakkata- lysator. | |
NL7414050A (nl) | Werkwijze voor het bereiden van een weefselbe- handelingspreparaat. | |
NL7416345A (nl) | Werkwijze voor de bereiding van een katalysator op drager en katalysator op drager, bereid met de werkwijze. | |
NL178085C (nl) | Werkwijze voor de bereiding van een verbeterde kleefstof. | |
NL162294C (nl) | Werkwijze voor het bereiden van een fungicide preparaat. | |
NL7415793A (nl) | Werkwijze voor het bereiden van een piperazi- nylchinazoline. | |
NL163135C (nl) | Werkwijze voor het bereiden van een katalysator. | |
NL7411312A (nl) | Werkwijze voor de bereiding van een farmaceu- tisch preparaat. | |
NL164184C (nl) | Werwijze voor het bereiden van een insekticide preparaat. | |
NL179447C (nl) | Werkwijze voor het bereiden van een voedingsmiddel. | |
NL171061C (nl) | Werkwijze voor de bereiding van een springstof. | |
NL7409809A (nl) | Werkwijze voor het bereiden van een multivita- minepreparaat. | |
NL176186C (nl) | Werkwijze voor de bereiding van een vast isohumulonpreparaat. | |
NL180902C (nl) | Werkwijze voor de bereiding van kunstvlees. | |
NL174009C (nl) | Werkwijze ter bereiding van een geconcentreerd middel voor staldesinfectie. | |
NL181553C (nl) | Werkwijze voor de bereiding van een virus-subeenheid-vaccin. | |
NL185824C (nl) | Werkwijze voor de bereiding van een farmaceutische doseringseenheid. | |
NL7415614A (nl) | Influenzavaccins en werkwijze ter bereiding daarvan. | |
NL7413323A (nl) | Werkwijze voor de bereiding van een veterinair preparaat. | |
NL7410876A (nl) | Werkwijze voor de bereiding van een ontzwave- lingskatalysator. | |
NL179542C (nl) | Werkwijze voor de bereiding van een anthelmintisch preparaat. | |
NL7412493A (nl) | Werkwijze voor de bereiding van een voedings- produkt voor herkauwers. | |
NL7409394A (nl) | Trifluormethylgesubstitueerde aminoarylsulfo- nylverbindingen en een werkwijze voor de berei- ding daarvan. | |
NL7412022A (nl) | Werkwijze voor het bereiden van een 4-hydroxy-5-azacumarienderivaat. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
A85 | Still pending on 85-01-01 | ||
SNR | Assignments of patents or rights arising from examined patent applications |
Owner name: EVANS MEDICAL LIMITED |
|
V4 | Discontinued because of reaching the maximum lifetime of a patent |